Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain langauage summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: The Catalytic DNA Topoisomerase II Inhibitor Dexrazoxane (ICRF-187) Induces Differentiation and Apoptosis in Human Leukemia K562 Cells, Molecular Pharmacology, March 2001, American Society for Pharmacology & Experimental Therapeutics (ASPET), DOI: 10.1124/mol.59.3.453.
You can read the full text:



Be the first to contribute to this page